Legato Capital Management »

Catalyst Pharmaceutical Partners shares owned by Legato Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $951k 48k 19.70
2025-06-30 $653k 30k 21.70
2025-03-31 $1.3M 54k 24.25

More positions owned by Legato Capital Management

Argan (AGX)
Ies Hldgs (IESC)
Stonex Group (SNEX)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
VSE Corporation (VSEC)
Kratos Defense & Security Solutions (KTOS)
Broadcom (AVGO)
Netflix (NFLX)
LSI Industries (LYTS)
Apple (AAPL)
I3 Verticals (IIIV)
Bgc Group Inc Cl A (BGC)
Agilysys (AGYS)
Spotify Technology Sa (SPOT)

View all positions for Legato Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners